steroid-sparing medication, as both active RMD and continuous high-dose glucocorticoid treatment have potential for maternal and fetal harm Pre-pregnancy or early pregnancy laboratory testing for relevant autoantibodies is recommended. Ascertaining anti-Ro/SSA, anti-La/SSB, and aPL status improves counseling regarding pregnancy and fetal risk. We strongly recommend testing for anti-Ro/SSA and anti-La/SSB once before or early in pregnancy in women with SLE or SLE-like disorders, Sj√∂gren's